Blood Proteins TRMP1 and Clusterin as Minimally Invasive Biomarkers of AR in Renal and Cardiac Transplants
Overview
Objectives/Goals My objective was to validate the ability of blood proteins TRMP1 and Clusterin to serve as minimally invasive biomarkers for diagnosis of Acute rejection in renal and cardiac transplant patients. Methods/Materials I tested previously collected samples from AR and stable patients using ELISA (Enzyme Linked Immunosorbent Assay)kits pre-coated with antibodies specific to the proteins I was testing for. The results of the experiments were determined using a Microplate Reader and data graphing software. There was much pipetting involved in transferring samples and chemical solutions from well to well on the ELISA plate. An analytical Scale/Balance was also used in the preparation of solutions (often needed to be diluted) Results Blood Proteins TRMP1 and Clusterin increased in samples of patients experience acute transplant rejection VS samples of patients with stable transplant status. Conclusions/Discussion Through ELISA test validation, I found blood proteins TRMP1 and Clusterin able to: 1. Evaluate the health of a transplanted kidney or heart (compared to stable) semi invasively. 2. Identify acute rejection from stable grafts in renal or cardiac transplant patients can con therefore serve as acute rejection specific biomarkers. 3. Possibly diagnose opportunistic infections such as CMV (cytomegalovirus) in an immunocompromised patient- Clusterin and TRMP1 concentration were lower than the stable in infected patients.
Summary statement
The ability of blood proteins TRMP1 and Clusterin to serve as minimally invasive biomarkers for acute transplant rejection diagnosis in renal and cardiac transplant patients.
Help received
Used lab equipment at Stanford University under the supervision of Tara Sigdel; Participant in Stanford Institutes of Medicine Summer Research Program, Science Fair coach (Don Van Ness) had my board laminated.
Competition history
- CSEF 2012
Resources
Related projects
ISEF · 2014
A Novel Device for the Detection of Chronic Transplant Rejection
CSEF · 2019
Identification of Novel Biomarkers for the Early Diagnosis of Acute Myocardial Infarction
ISEF · 2021
Data Mining to Identify Therapeutic Targets for Transplant Rejection
ISEF · 2025
Knockdown of BETA2 Microglobulin in MHC 1 Molecule to Prevent Transplant Rejection in RPE Cells
ISEF · 2022
The Future of Organ Replacement: Using Bioinformatics To Determine the Best Protein Environment To Bioengineer the Optimum Renal Vasculature System Using hiPSCs
ISEF · 2020
Bryostatin-1 and Its Effect on Neutrophil Transmigration Through the Endothelial Layer in Liver and Kidney Ischemia-Reperfusion Injury Models
CSEF · 2016
Maintaining Viability in Cellular Therapies for Age-Related Macular Degeneration during Cryopreservation
CSEF · 2011
Evaluation of Monoclonal Antibodies for HER-2 Neu Status in Breast Cancer
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: California Science & Engineering Fair public projects